SEC Company Response from Quantum Cyber N.V. (QUCY) — Dec 22, 2025
Quantum Cyber N.V.
Date: Dec. 22, 2025 · CIK: 0001874252 · Accession: 0001213900-25-124689
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-291979
Letter
Re: Mainz Biomed N.V.
December 22, 2025
Via EDGAR
U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549-4720
Registration Statement on Form F-3
File No. 333-291979
Acceleration Request
Requested Date: December 29, 2025
Requested Time: 5:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Mainz Biomed N.V. (the "Company") hereby requests that the above-referenced Registration Statement on Form F-3 (Registration No. 333-291979) (the "Registration Statement") be declared effective at the "Requested Date" and "Requested Time" set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Ortoli Rosenstadt LLP, by calling Tim Dockery at (212) 829-8946.
MAINZ BIOMED N.V.
By: /s/ William Caragol
Name: William Caragol
Title: Chief Financial Officer
Show Raw Text
CORRESP 1 filename1.htm December 22, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549-4720 Re: Mainz Biomed N.V. Registration Statement on Form F-3 File No. 333-291979 Acceleration Request Requested Date: December 29, 2025 Requested Time: 5:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Mainz Biomed N.V. (the "Company") hereby requests that the above-referenced Registration Statement on Form F-3 (Registration No. 333-291979) (the "Registration Statement") be declared effective at the "Requested Date" and "Requested Time" set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Ortoli Rosenstadt LLP, by calling Tim Dockery at (212) 829-8946. MAINZ BIOMED N.V. By: /s/ William Caragol Name: William Caragol Title: Chief Financial Officer